ICD-10-CM Billable Code

I27.24

Chronic thromboembolic pulmonary hypertension

Clinical Classification Guidelines

Inclusion Terms

  • Group 4 pulmonary hypertension

Code Also

  • associated pulmonary embolism, if applicable (I26.-, I27.82)

Medical Intelligence & Overview

Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious condition characterized by high blood pressure in the arteries of the lungs due to unresolved blood clots. This condition falls under Group 4 pulmonary hypertension, indicating its specific cause related to blood clots that obstruct pulmonary arteries. Over time, these blockages can lead to increased strain on the right side of the heart, potentially causing heart failure if not properly managed. Recognizing and understanding CTEPH is crucial for timely intervention and improved health outcomes.

Causes & Symptoms

Clinical Causes: Previous episodes of pulmonary embolism (blood clots in the lungs) that do not fully resolve Incomplete removal of blood clots following an acute pulmonary embolism Formation of new blood clots in the pulmonary arteries Underlying blood clotting disorders that increase the risk of thrombosis Anatomical abnormalities of the pulmonary arteries that promote clot formation or impede blood flow

Key Symptoms: Shortness of breath, especially during exertion Fatigue and weakness Chest pain or discomfort Dizziness or fainting spells Swelling in the legs or ankles Palpitations or irregular heartbeat Some individuals may have symptoms that develop gradually over time

Diagnostic & Treatment

Diagnosis Path: Detecting CTEPH involves a combination of medical history assessment, physical examination, and specialized tests. These typically include: - **Imaging tests:** Ventilation-perfusion (V/Q) scan, CT pulmonary angiography, and MRI to visualize blood flow and potential obstructions in pulmonary arteries. - **Echocardiogram:** To evaluate the heart's right ventricular function and estimate pulmonary artery pressures. - **Right heart catheterization:** A definitive test measuring the pressures within the pulmonary arteries directly. - **Blood tests:** To rule out other causes and assess overall health. Early diagnosis is critical for effective management and preventing the progression of the disease.

Treatment Protocols: Managing CTEPH involves several approaches aimed at reducing pulmonary artery pressure and improving blood flow. Treatment options include: - **Anticoagulation therapy:** To prevent new clots from forming. - **Pulmonary endarterectomy:** Surgical removal of organized clots from the pulmonary arteries, often curative. - **Balloon pulmonary angioplasty:** A minimally invasive procedure to open narrowed or blocked arteries. - **Medications:** Such as pulmonary vasodilators, including endothelin receptor antagonists, phosphodiesterase-5 inhibitors, or soluble guanylate cyclase stimulators, to lower blood pressure in the lungs. - **Supportive therapies:** Oxygen therapy and management of right heart failure symptoms. Treatment plans are tailored to the individual's condition and overall health, often involving a multidisciplinary team. Regular follow-up and monitoring are essential to assess treatment effectiveness and adjust therapies as needed.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is I27.24 a billable ICD-10 code?
Yes, I27.24 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report I27.24?
Clinical documentation must specify the nature of Chronic thromboembolic pulmonary hypertension and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

chronic pulmonary hypertension thromboembolic